imipramine has been researched along with bupropion in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (24.56) | 18.7374 |
| 1990's | 7 (12.28) | 18.2507 |
| 2000's | 11 (19.30) | 29.6817 |
| 2010's | 24 (42.11) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Boswell, GE; Cooper, BR; Kelley, JL; Musso, DL; Soroko, FE | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Barrett, JE; Zhang, L | 1 |
| Griffiths, RR; Lamb, RJ | 1 |
| Davidson, J; Pelton, S | 1 |
| Barnes, JC; Costall, B; Domeney, AM; Naylor, RJ | 1 |
| Bigger, JT; Giardina, EG; Glassman, AH; Johnson, LL; Roose, SP; Walsh, BT | 1 |
| Clifford, DB; Hicks, FG; Rutherford, JL; Zorumski, CF | 1 |
| Bass, JL; Branconnier, RJ; Cole, JO; Ghazvinian, S; Oxenkrug, GF; Spera, KF | 1 |
| Borenstein, M; Cole, K; Howard, A; Kane, JM; Sarantakos, S | 1 |
| Shopsin, B | 1 |
| Peck, AW; Stern, WC; Watkinson, C | 1 |
| Fowle, AS; Peck, AW; Rogers, HJ; Spector, RG | 2 |
| Cloutier, G; Cubeddu, LX; Grippo, R; Gross, K; Harden, TK; Knowlton, G; Lerea, L; Shakarjian, M; Stat, M; Tanner, L | 1 |
| Jackson, W; Liskin, B; Roose, SP; Walsh, BT | 1 |
| Cooper, BR; Hester, TJ; Maxwell, RA | 1 |
| Breese, GR; Mueller, RA; Pappas, BA; Vogel, RA; Wilson, JH | 1 |
| Preskorn, SH | 1 |
| Short, DD; Workman, EA | 1 |
| Abdel el-Latif, HA; Ammon, HP; el-Dakhakhny, M | 1 |
| Preskorn, SH; Shad, MU | 1 |
| Bourin, M; Dailly, E; David, DJ; Hascoët, M; Ripoll, N | 1 |
| Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A | 1 |
| Nikiforuk, A; Wesołowska, A | 1 |
| Fujitani, Y; Gomita, Y; Kawasaki, H; Kitagawa, K; Kitamura, Y; Miyazaki, T; Sagara, H; Sendo, T; Shibata, K | 1 |
| Costentin, J; do Rego, JC; Janin, F; Naudin, B; Rates, S; Viana, A | 1 |
| Harvey, I; Lilford, R; Song, F | 1 |
| Chang, L; Kim, HW; Lee, HJ; Rao, JS; Rapoport, SI | 1 |
| Arias, HR; Bouzat, C; Feuerbach, D; Gumilar, F; Jozwiak, K; Moaddel, R; Rosenberg, A; Targowska-Duda, KM; Wainer, IW | 1 |
| Lo, V; Maggio, L | 1 |
| Balci, F; Campbell, U; Hanania, T; Olivier, BE; Paterson, NE | 1 |
| Hara, H; Hayashi, E; Kinoshita, M; Kuratani, K | 1 |
| Hara, H; Hayashi, E; Kinoshita, M; Kuratani, K; Shimamura, M | 1 |
| Costentin, J; Do Rego, JC; Müller, LG; Nunes, JM; Rates, SM; Stein, AC; Stolz, ED; Viana, AF; von Poser, GL | 1 |
| Młyniec, K; Nowak, G | 2 |
| Cadeddu, R; Carboni, E; Ibba, M; Sadile, A | 1 |
| Arias, HR; Feuerbach, D; García-Colunga, J; Jozwiak, K; Mihailescu, S; Miranda-Morales, M; Targowska-Duda, KM; Vázquez-Gómez, E | 1 |
| Krakowska, A; Mlyniec, K; Nowak, G; Opoka, W; Ostachowicz, B; Reczynski, W | 1 |
| Leal, RB; Lopes, MW; Manosso, LM; Moretti, M; Neis, VB; Rodrigues, AL | 1 |
| Betti, AH; Herzfeldt, V; Müller, LG; Rates, SM; Stolz, ED | 1 |
| Arias, HR; Feuerbach, D; Ortells, MO | 1 |
| Ishibashi, T; Iwadate, R; Kawai, H; Kawashima, Y; Kudo, N; Mitsumoto, A | 1 |
| Andrade, CH; Barbosa-Filho, JM; Capibaribe, VC; Carvalho, AMR; Chaves Filho, AJM; Chaves, RC; Fonteles, MMF; Gutierrez, SJC; Macedo, DS; Mallman, ASV; Mottin, M; Oliveira, ICM; Oliveira, NF; Rebouças, MO; Sartori, DP; Silva, DMA; Sousa, FCF; Valentim, JT | 1 |
6 review(s) available for imipramine and bupropion
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Imipramine; Propiophenones; Seizures | 1983 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Fluoxetine; Humans; Imipramine; Trazodone | 1993 |
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Guanfacine; Humans; Imipramine; Nortriptyline; Propylamines | 2005 |
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome | 2008 |
7 trial(s) available for imipramine and bupropion
| Article | Year |
|---|---|
Forms of atypical depression and their response to antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Isocarboxazid; Male; Middle Aged; Monoamine Oxidase Inhibitors; Panic; Phenelzine; Propiophenones; Psychological Tests; Sex Factors; Somatoform Disorders | 1986 |
Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure.
Topics: Aged; Angiocardiography; Antidepressive Agents; Blood Pressure; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Imipramine; Male; Middle Aged; Propiophenones; Random Allocation | 1987 |
Clinical pharmacology of bupropion and imipramine in elderly depressives.
Topics: Age Factors; Aged; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Memory; Middle Aged; Placebos; Propiophenones; Psychomotor Performance; Random Allocation | 1983 |
Safety and efficacy of bupropion in elderly patients: preliminary observations.
Topics: Age Factors; Aged; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Propiophenones; Psychiatric Status Rating Scales; Random Allocation | 1983 |
Failure of bupropion to affect tyramine response in man.
Topics: Adult; Antidepressive Agents; Blood Pressure; Bupropion; Dose-Response Relationship, Drug; Humans; Imipramine; Male; Propiophenones; Tyramine | 1983 |
Bupropion does not antagonize cardiovascular actions of clonidine in normal subjects and spontaneously hypertensive rats.
Topics: Adult; Animals; Blood Platelets; Blood Pressure; Bupropion; Clonidine; Desipramine; Heart Rate; Humans; Imipramine; In Vitro Techniques; Male; Propiophenones; Rats; Rats, Inbred Strains; Tritium; Yohimbine | 1984 |
Failure of bupropion to affect the response to tyramine in man.
Topics: Adult; Blood Pressure; Bupropion; Humans; Imipramine; Male; Propiophenones; Tyramine | 1981 |
44 other study(ies) available for imipramine and bupropion
| Article | Year |
|---|---|
(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Dose-Response Relationship, Drug; Mice; Morpholines; Norepinephrine; Rats | 1996 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Imipramine as a discriminative stimulus.
Topics: Amitriptyline; Amphetamine; Animals; Bupropion; Cocaine; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Imipramine | 1991 |
Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.
Topics: Animals; Antidepressive Agents; Bupropion; Conditioning, Operant; Discrimination, Psychological; Imipramine; Isoquinolines; Male; Nomifensine; Papio; Propiophenones; Rats; Rats, Inbred Strains; Reinforcement Schedule; Self Administration; Substance-Related Disorders | 1990 |
Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
Topics: Amitriptyline; Animals; Antidepressive Agents; Bupropion; Dopamine Antagonists; Female; Imipramine; Lithium; Motor Activity; Nomifensine; Nucleus Accumbens; Propiophenones; Rats; Rats, Inbred Strains; Septal Nuclei | 1986 |
Acute effects of antidepressants on hippocampal seizures.
Topics: Amitriptyline; Animals; Anticonvulsants; Antidepressive Agents; Bupropion; Desipramine; Epilepsy; Hippocampus; Imipramine; Maprotiline; Propiophenones; Rats; Trazodone | 1985 |
Bupropion's prophylactic efficacy in bipolar affective illness.
Topics: Acute Disease; Adult; Antidepressive Agents; Bipolar Disorder; Bupropion; Drug Administration Schedule; Female; Humans; Imipramine; Lithium; Male; Middle Aged; Pedigree; Propiophenones; Recurrence | 1983 |
Imipramine-induced inappropriate ADH secretion.
Topics: Aged; Antidepressive Agents; Bupropion; Depressive Disorder; Female; Humans; Hyponatremia; Imipramine; Inappropriate ADH Syndrome; Propiophenones | 1984 |
Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Brain; Bupropion; Catecholamines; Dopamine; Imipramine; Locomotion; Male; Models, Biological; Propiophenones; Rats | 1980 |
Drug alterations of punished responding after chlordiazepoxide: possible screen for agents useful in minimal brain dysfunction.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Bupropion; Chlordiazepoxide; Conditioning, Operant; Dextroamphetamine; Drug Evaluation, Preclinical; Humans; Imipramine; Male; Methylphenidate; Phenobarbital; Propiophenones; Punishment; Rats | 1981 |
Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic islets.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Female; Glucose; Imipramine; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Maprotiline; Mice | 1996 |
A possible bupropion and imipramine interaction.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Humans; Imipramine; Middle Aged | 1997 |
Antidepressant-like effects in various mice strains in the tail suspension test.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Citalopram; Depression; Desipramine; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hindlimb Suspension; Imipramine; Male; Mice; Mice, Inbred Strains; Paroxetine; Selective Serotonin Reuptake Inhibitors; Species Specificity | 2003 |
The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Drug Synergism; Imipramine; Injections, Intraperitoneal; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides | 2008 |
Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Imipramine; Male; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swimming | 2008 |
Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels.
Topics: Animals; Antidepressive Agents; Bupropion; Cerebral Cortex; Corticosterone; Cyclohexanes; Drug Administration Schedule; Humans; Hypericum; Imipramine; Mice; Mice, Inbred Strains; Motor Activity; Plant Extracts; Restraint, Physical; Swimming | 2008 |
Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder?
Topics: Animals; Arachidonic Acid; Bipolar Disorder; Bupropion; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Drug Administration Schedule; Frontal Lobe; Humans; Imipramine; Male; Phospholipases A2, Calcium-Independent; Phospholipases A2, Cytosolic; Phosphorylation; Rats; Signal Transduction; Transcription Factor AP-2; Up-Regulation | 2010 |
Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states.
Topics: Animals; Binding, Competitive; Biological Transport; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Calcium; Cell Line; Drug Discovery; Electric Conductivity; Humans; Imipramine; Immobilized Proteins; Ion Channel Gating; Kinetics; Mice; Models, Molecular; Muscles; Nicotinic Antagonists; Piperidines; Protein Binding; Protein Conformation; Pyridines; Receptors, Nicotinic; Thermodynamics; Torpedo | 2009 |
Clinical inquiries. What's best when a patient doesn't respond to the maximum dose of an antidepressant?
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Cognitive Behavioral Therapy; Depression; Humans; Imipramine; Lithium; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure | 2010 |
The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Topics: Animals; Antidepressive Agents; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Desipramine; Diazepam; Dopamine Uptake Inhibitors; Fluvoxamine; Haloperidol; Imipramine; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology | 2011 |
Pharmacologically distinctive behaviors other than burying marbles during the marble burying test in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Bupropion; Diazepam; Exploratory Behavior; Fluvoxamine; Imipramine; Male; Mice; Motor Activity | 2010 |
Automated experimental system capturing three behavioral components during murine forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Desipramine; Equipment Design; Fluvoxamine; Image Interpretation, Computer-Assisted; Imipramine; Male; Mice; Mice, Inbred Strains; Pattern Recognition, Automated; Psychomotor Performance; Swimming; Video Recording | 2011 |
Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzazepines; Biogenic Monoamines; Bupropion; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fenclonine; Fluoxetine; Hypericum; Imipramine; Immobility Response, Tonic; Locomotion; Male; Mice; Mice, Inbred Strains; Phloroglucinol; Plant Extracts; Prazosin; Rats; Rats, Wistar; Receptors, Catecholamine; Sulpiride; Vesicular Monoamine Transport Proteins; Yohimbine | 2012 |
GPR39 up-regulation after selective antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Citalopram; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptors, G-Protein-Coupled; Up-Regulation; Zinc | 2013 |
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy?
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Male; Morpholines; Norepinephrine; Rats, Sprague-Dawley; Reboxetine; Septal Nuclei; Time Factors | 2014 |
Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Binding, Competitive; Bupropion; Choline; Dorsal Raphe Nucleus; Hippocampus; Imipramine; Molecular Docking Simulation; Neurons; Rats, Wistar | 2014 |
Chronic but not acute antidepresant treatment alters serum zinc/copper ratio under pathological/zinc-deficient conditions in mice.
Topics: Animals; Antidepressive Agents; Bupropion; Citalopram; Copper; Depression; Disease Models, Animal; Imipramine; Male; Mice; Morpholines; Reboxetine; Sodium Chloride; Zinc | 2014 |
Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice.
Topics: Agmatine; Animals; Antidepressive Agents; Bupropion; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluoxetine; Hindlimb Suspension; Imipramine; Mice; Motor Activity | 2015 |
Synergistic interaction between diene valepotriates from Valeriana glechomifolia Meyer (Valerianaceae) and classical antidepressants: an isobolographic analysis.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Drug Synergism; Imipramine; Iridoids; Locomotion; Male; Mice; Motor Activity; Swimming; Valerian | 2015 |
Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Bupropion; Citalopram; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Drug Administration Schedule; Frontal Lobe; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptor, trkB; Receptors, G-Protein-Coupled; Signal Transduction; Up-Regulation; Zinc | 2015 |
Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors.
Topics: Animals; Azides; Binding, Competitive; Bupropion; Imipramine; Ligands; Molecular Docking Simulation; Protein Conformation; Receptors, Nicotinic | 2016 |
Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Circadian Rhythm; Depression; Dopamine; Fluoxetine; Imipramine; Male; Mice; Mice, Inbred C57BL; Movement; Norepinephrine; Time Factors; Venlafaxine Hydrochloride | 2019 |
Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Imipramine; Mice; Molecular Docking Simulation; Monoamine Oxidase; Norepinephrine; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tyramine | 2020 |